Literature DB >> 19774369

A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI images.

Juha Martola1, Jakob Bergström, Sten Fredrikson, Leszek Stawiarz, Jan Hillert, Yi Zhang, Olof Flodmark, Anders Lilja, Anders Ekbom, Peter Aspelin, Maria Kristoffersen Wiberg.   

Abstract

INTRODUCTION: Multiple sclerosis (MS) has a variable progression with an early onset of atrophy. Individual longitudinal radiological evaluations (over decades) are difficult to perform due to the limited availability of magnetic resonance imaging (MRI) in the past, patients lost in follow-up, and the continuous updating of scanners. We studied a cohort with widespread disease duration at baseline. The observed individual atrophy rates over time of 10 years represented four decades of disease span.
METHODS: Thirty-seven MS patients (age range 24-65 years with disease duration 1-33 years) were consecutively selected and evaluated with MRI at baseline 1995 and in 1996. They were followed up for a decade (mean of 9.25 years, range 7.3-10 years) up to 2003-2005. Brain parenchymal volume and volumes of the supratentorial ventricles were analyzed with semi-automated volumetric measurements at three time points (1995, 1996, and 2003-2005).
RESULTS: Volumetric differences were found over shorter periods of time (1-7 months); however, differences vanished by the end of follow-up. A uniform longitudinal decrease in brain volume and increase in ventricle volumes were found. Frontal horn width (1D) correlated strongest to 3D measures. No statistical differences of atrophy rates between MS courses were found. Supratentorial ventricular volumes were associated with disability and this association persisted during follow-up.
CONCLUSION: Despite variable clinical courses, the degenerative effects of MS progression expressed in brain atrophy seem to uniformly progress over longer periods of time. These volumetric changes can be detected using 1D and 2D measurements performed on a routine PACS workstation.

Entities:  

Mesh:

Year:  2009        PMID: 19774369     DOI: 10.1007/s00234-009-0593-9

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  31 in total

1.  Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Authors:  R H S R Roxburgh; S R Seaman; T Masterman; A E Hensiek; S J Sawcer; S Vukusic; I Achiti; C Confavreux; M Coustans; E le Page; G Edan; G V McDonnell; S Hawkins; M Trojano; M Liguori; E Cocco; M G Marrosu; F Tesser; M A Leone; A Weber; F Zipp; B Miterski; J T Epplen; A Oturai; P Soelberg Sørensen; E G Celius; N Téllez Lara; X Montalban; P Villoslada; A M Silva; M Marta; I Leite; B Dubois; J Rubio; H Butzkueven; T Kilpatrick; M P Mycko; K W Selmaj; M E Rio; M Sá; G Salemi; G Savettieri; J Hillert; D A S Compston
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

2.  A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis.

Authors:  T L Luks; D E Goodkin; S J Nelson; S Majumdar; P Bacchetti; D Portnoy; R Sloan
Journal:  Mult Scler       Date:  2000-10       Impact factor: 6.312

3.  Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype.

Authors:  Elisabetta Pagani; Maria A Rocca; Antonio Gallo; Marco Rovaris; Vittorio Martinelli; Giancarlo Comi; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

4.  One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging.

Authors:  J Martola; L Stawiarz; S Fredrikson; J Hillert; J Bergström; O Flodmark; P Aspelin; M Kristoffersen Wiberg
Journal:  Acta Radiol       Date:  2009-10       Impact factor: 1.990

5.  Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.

Authors:  Dana Horakova; Michael G Dwyer; Eva Havrdova; Jennifer L Cox; Ondrej Dolezal; Niels Bergsland; Brett Rimes; Zdenek Seidl; Manuela Vaneckova; Robert Zivadinov
Journal:  J Neurol Sci       Date:  2009-01-24       Impact factor: 3.181

6.  One year follow up study of primary and transitional progressive multiple sclerosis.

Authors:  V L Stevenson; D H Miller; S M Leary; M Rovaris; F Barkhof; B Brochet; V Dousset; M Filippi; R Hintzen; X Montalban; C H Polman; A Rovira; J de Sa; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

7.  A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging.

Authors:  Rachael I Scahill; Chris Frost; Rhian Jenkins; Jennifer L Whitwell; Martin N Rossor; Nick C Fox
Journal:  Arch Neurol       Date:  2003-07

8.  Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

Authors:  N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

9.  Detection of ventricular enlargement in patients at the earliest clinical stage of MS.

Authors:  P A Brex; R Jenkins; N C Fox; W R Crum; J I O'Riordan; G T Plant; D H Miller
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

10.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

Authors:  D T Chard; C M Griffin; G J M Parker; R Kapoor; A J Thompson; D H Miller
Journal:  Brain       Date:  2002-02       Impact factor: 13.501

View more
  10 in total

1.  Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes.

Authors:  Maria José Magraner; Isabel Bosca; Maria Simó-Castelló; Gracian García-Martí; Angel Alberich-Bayarri; Francisco Coret; Jose C Alvarez-Cermeño; Luís Martí-Bonmatí; Luisa M Villar; Bonaventura Casanova
Journal:  Neuroradiology       Date:  2011-02-16       Impact factor: 2.804

Review 2.  Automated detection of multiple sclerosis lesions in serial brain MRI.

Authors:  Xavier Lladó; Onur Ganiler; Arnau Oliver; Robert Martí; Jordi Freixenet; Laia Valls; Joan C Vilanova; Lluís Ramió-Torrentà; Alex Rovira
Journal:  Neuroradiology       Date:  2011-12-20       Impact factor: 2.804

3.  Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.

Authors:  Katherine C Gao; Govind Nair; Irene C M Cortese; Alan Koretsky; Daniel S Reich
Journal:  Neuroimage       Date:  2014-06-16       Impact factor: 6.556

4.  Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years.

Authors:  R Zivadinov; N Bergsland; O Dolezal; S Hussein; Z Seidl; M G Dwyer; M Vaneckova; J Krasensky; J A Potts; T Kalincik; E Havrdová; D Horáková
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-11       Impact factor: 3.825

5.  Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.

Authors:  Hagen H Kitzler; Jason Su; Michael Zeineh; Cynthia Harper-Little; Andrew Leung; Marcelo Kremenchutzky; Sean C Deoni; Brian K Rutt
Journal:  Neuroimage       Date:  2011-09-02       Impact factor: 6.556

6.  Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling.

Authors:  Blake C Jones; Govind Nair; Colin D Shea; Ciprian M Crainiceanu; Irene C M Cortese; Daniel S Reich
Journal:  Neuroimage Clin       Date:  2013-08-13       Impact factor: 4.881

7.  A putative Alzheimer's disease risk allele in PCK1 influences brain atrophy in multiple sclerosis.

Authors:  Zongqi Xia; Lori B Chibnik; Bonnie I Glanz; Maria Liguori; Joshua M Shulman; Dong Tran; Samia J Khoury; Tanuja Chitnis; Todd Holyoak; Howard L Weiner; Charles R G Guttmann; Philip L De Jager
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

8.  Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.

Authors:  Ashley D Radomski; Christopher Power; Scot E Purdon; Derek J Emery; Gregg Blevins; Kenneth G Warren; Esther Fujiwara
Journal:  BMC Neurol       Date:  2015-04-23       Impact factor: 2.474

Review 9.  The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.

Authors:  Maria A Rocca; Giancarlo Comi; Massimo Filippi
Journal:  Front Neurol       Date:  2017-09-04       Impact factor: 4.003

10.  Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.

Authors:  Anders Tisell; Olof Dahlqvist Leinhard; Jan Bertus Marcel Warntjes; Anne Aalto; Örjan Smedby; Anne-Marie Landtblom; Peter Lundberg
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.